Personalized drug therapy; the genome, the chip and the physician
Editors' Report 2004
Clinical pharmacology of DP-b99 in healthy volunteers
Investigation of the effects of physiological and vasodilation-induced autonomic activation on the QTc Interval in healthy male subjects
Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration
Pharmacokinetic evidence for the induction of lopinavir metabolism by efavirenz
Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia
Dexamethasone as a probe for vinorelbine clearance
Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract
Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine
The role of CYP2C and CYP3A in the disposition of 3-keto-desogestrel after administration of desogestrel
Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK
Suboptimal choices and dosing of statins at start of therapy
Queen Mary Utilization of Antihypertensive Drugs Study
Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin®
Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents
Bosentan decreases the plasma concentration of sildenafil when coprescribed in pulmonary hypertension
Pharmacotherapy of Depression
Inadvertent intrathecal administration of rifampicin